{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:57:46Z","timestamp":1773694666721,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jchromb.2021.122714","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T23:41:22Z","timestamp":1618962082000},"page":"122714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of LC\/MS\/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies"],"prefix":"10.1016","volume":"1174","author":[{"given":"Shridhar","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha Krishan","family":"Shandil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kamal","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Siva","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hima","family":"Mahesh K.U.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0204-2138","authenticated-orcid":false,"given":"Niraj","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanan","family":"Surendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122714_b0005","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2021.122714_b0010","first-page":"359","article-title":"Disposition of tricyclic nucleoside-5\u2032-monophosphate in blood and plasma of patients during phase I and II clinical trials","volume":"70","author":"Powis","year":"1986","journal-title":"Cancer Treat Reports"},{"key":"10.1016\/j.jchromb.2021.122714_b0015","first-page":"3608","article-title":"Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule","volume":"44","author":"Feun","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2021.122714_b0020","first-page":"3147","article-title":"Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5\u2032-phosphate using a weekly intravenous regimen","volume":"46","author":"Schilcher","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jchromb.2021.122714_b0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10637-010-9479-2","article-title":"Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT","volume":"29","author":"Garrett","year":"2011","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.jchromb.2021.122714_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425241003610633","article-title":"Drug delivery by red blood cells: vascular carriers designed by mother nature","volume":"7","author":"Muzykantov","year":"2010","journal-title":"Expert Opinion in Drug Delivery"},{"key":"10.1016\/j.jchromb.2021.122714_b0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/tde.15.34","article-title":"Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier","volume":"6","author":"Villa","year":"2015","journal-title":"Therapeutic Delivery"},{"issue":"5","key":"10.1016\/j.jchromb.2021.122714_b0040","article-title":"Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia telangiectasia patients: results of a phase 2 trial","volume":"9","author":"Chessa","year":"2014","journal-title":"Orpha net Journal of Rare Diseases"},{"key":"10.1016\/j.jchromb.2021.122714_b0045","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1111\/bph.13203","article-title":"The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGF\u03b2-induced pulmonary fibrosis","volume":"172","author":"Abdalla","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122714_b0050","first-page":"L750","article-title":"Delayed Akt suppression in the lipopolysaccharide induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cells","volume":"318","author":"Artham","year":"2019","journal-title":"American Journal of Physiology: Lung Cell Molecular Physiology"},{"key":"10.1016\/j.jchromb.2021.122714_b0055","doi-asserted-by":"crossref","first-page":"L45","DOI":"10.1152\/ajplung.00124.2020","article-title":"Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?","volume":"319","author":"Somanath","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jchromb.2021.122714_b0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)81749-1","article-title":"High-performance liquid Chromatographic assays of the antineoplastic agent tricyclic nucleoside 5'-phosphate its exposition in rabbit","volume":"283","author":"Basseches","year":"1982","journal-title":"J. Chromatography"},{"key":"10.1016\/j.jchromb.2021.122714_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.108.145854","article-title":"The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1-\/- mouse erythrocytes","volume":"329","author":"Endres","year":"2009","journal-title":"J. Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jchromb.2021.122714_b0070","doi-asserted-by":"crossref","unstructured":"T. Eckle, L. Fullbier, M. Wehrmann, J. Khoury, M. Mittelbronn, J. Ibla, P. Rosenberger, H.K. Eltzschig, Identification of Ectonucleotidases CD39 and CD73 in Innate Protection during Acute Lung Injury. J. Immunology 2007, 178 (12): 8227-8137. doi.org\/10.4049\/jimmunol.178.12.8127.","DOI":"10.4049\/jimmunol.178.12.8127"},{"key":"10.1016\/j.jchromb.2021.122714_b0075","unstructured":"P.J. Basseches, G. Powis Metabolism and Disposition of 3-Amino-1,5-dihydro-5-methyl-1-#-Dribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene in the rat. Cancer Research 1984, 44:3672-3678. [PubMed: 6540141]."},{"issue":"11","key":"10.1016\/j.jchromb.2021.122714_b0080","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/cdd.2010.63","article-title":"The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane","volume":"17","author":"Berndt","year":"2010","journal-title":"Cell Death Differ."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322100194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322100194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:03:49Z","timestamp":1761606229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322100194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":16,"alternative-id":["S157002322100194X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122714","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of LC\/MS\/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122714"}}